LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,174,000 | -74.8% | 3,383,000 | -74.8% | 1.01% | -66.8% |
| Q3 2017 | $24,490,000 | +20.8% | 13,403,000 | +9.5% | 3.03% | +14.8% |
| Q2 2017 | $20,273,000 | +110.5% | 12,245,000 | +89.3% | 2.64% | +84.6% |
| Q1 2017 | $9,632,000 | -16.9% | 6,470,000 | -19.2% | 1.43% | -18.1% |
| Q4 2016 | $11,584,000 | +24.0% | 8,010,000 | +25.2% | 1.75% | +26.8% |
| Q3 2016 | $9,344,000 | -33.5% | 6,400,000 | -24.0% | 1.38% | -36.7% |
| Q2 2016 | $14,058,000 | +1.4% | 8,425,000 | -7.4% | 2.18% | -6.4% |
| Q1 2016 | $13,870,000 | +16.1% | 9,100,000 | +17.9% | 2.33% | +31.6% |
| Q4 2015 | $11,947,000 | +28.1% | 7,720,000 | +6.9% | 1.77% | +14.9% |
| Q3 2015 | $9,323,000 | – | 7,220,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |